Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study (Q44253501)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study |
scientific article |
Statements
1 reference
Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study (English)
1 reference
W Jonat
1 reference
M Kaufmann
1 reference
W Sauerbrei
1 reference
R Blamey
1 reference
J Cuzick
1 reference
M Namer
1 reference
I Fogelman
1 reference
J C de Haes
1 reference
A de Matteis
1 reference
A Stewart
1 reference
W Eiermann
1 reference
I Szakolczai
1 reference
M Palmer
1 reference
M Schumacher
1 reference
M Geberth
1 reference
B Lisboa
1 reference
Zoladex Early Breast Cancer Research Association Study
1 reference
1 December 2002
1 reference
1 reference
Identifiers
1 reference